PathoFinder is a privately owned molecular diagnostics brand established in 2004. They specialize in the development and commercialization of syndromic molecular diagnostics panels, with a particular emphasis on infectious diseases. Their proprietary 2SmartFinder® technology enables the detection and differentiation of up to 24 viral, bacterial, fungal, and parasitic pathogens in a single assay.

Based in Maastricht, The Netherlands, PathoFinder's founder, Guus Simons, PhD, has a strong background in molecular biology and extensive experience in the field. The brand's mission is to improve healthcare through innovative comprehensive diagnostics, while their vision focuses on continuously improving the diagnosis of infections and promptly adding new targets when novel pathogens emerge. PathoFinder places a strong emphasis on quality control and is EN ISO 13485:2016 certified for the design, development, manufacturing, and distribution of their in-vitro diagnostics.

Additionally, they meet the requirements of Directive 98/79/EC on IVD Medical Devices. With a wide range of products available, including panels for respiratory, gastroenteritis, STD, and meningitis testing, PathoFinder is dedicated to providing accurate, timely, and user-friendly diagnostic solutions. Ensure that your healthcare needs are met with PathoFinder's cutting-edge molecular diagnostics technology